Counternarcotics: Lessons from the U.S. Experience in Afghanistan
Abstract
Since 2002, stemming opium poppy cultivation and drug production in Afghanistan has been an important, though not primary, goal for the United States, its coalition partners, and the Afghan government. While very little Afghan heroin comes to the United States, the Afghan drug trade has undermined reconstruction and security goals in many ways, including by financing insurgent groups, fueling government corruption, eroding state legitimacy, and exacting an enormous human and financial toll. From fiscal year (FY) 2002 through FY 2017, the U.S. government allocated approximately $8.62 billion for counternarcotics efforts in Afghanistan. This included more than $7.28 billion for programs with a substantial counternarcotics focus and $1.34 billion on programs that included a counternarcotics component.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2018
- Accession Number
- AD1139386
Entities
Organizations
- Special Inspector General for Afghanistan Reconstruction